This story originally ran on April 29.

Aided by market acceptance of its new mass spectrometers introduced in the fall, Life Technologies said that results for its mass-spec division were better than expected in the first quarter.

The company also this week reported that total receipts for the three months ended March 31 inched up 1 percent to around $785 million.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.